Latin America In Vitro Diagnostics (IVD) Quality Control Market (2025-2030)
The Latin America In Vitro Diagnostics (IVD) Quality Control Market was valued at $2.5 Million in 2025 and projected to reach to $2.85 Million by 2030, representing a compound annual growth rate of CAGR 2.6%. The Latin American IVD Quality Control Market is positioned for steady growth as healthcare systems across the region prioritize diagnostic accuracy and regulatory compliance.
Latin America In Vitro Diagnostics (IVD) Quality Control Market Trends and Insights
- Rest Of Middle East & Africa represents a developing segment within the broader Middle East & Africa region, characterized by emerging healthcare infrastructure and increasing diagnostic testing demand.
- The market in Rest Of Middle East & Africa is driven by rising awareness of laboratory quality standards, regulatory compliance requirements, and the expansion of diagnostic facilities across smaller and mid-sized healthcare systems. Rest Of Middle East & Africa faces unique challenges including limited access to advanced quality control technologies, cost constraints, and varying regulatory frameworks across individual markets.
- However, Rest Of Middle East & Africa is experiencing gradual modernization of laboratory networks and increased investment in healthcare diagnostics.
- The modest growth trajectory of Rest Of Middle East & Africa reflects the region's developing market maturity compared to established diagnostic hubs, yet presents opportunities for quality control solution providers targeting emerging economies and underserved healthcare segments..
Key Market Statistics
- CAGR (2025-2030) CAGR 2.6%
- Market Size, 2025 ~USD 2.5 Million
- Forecast, 2030 ~USD 2.85 Million
- Geography Latin America
Latin America In Vitro Diagnostics (IVD) Quality Control Market Overview
Market Growth Trajectory :
Latin America's IVD Quality Control Market is valued at USD 2.5 million in 2025 and is projected to reach USD 2.85 million by 2030, with a CAGR of 2.6%, reflecting steady but moderate expansion driven by improving diagnostic infrastructure.
Brazil's Market Leadership :
Brazil dominates the Latin American IVD Quality Control segment with a market size of USD 32.6 million, representing the largest opportunity in the region and serving as a hub for diagnostic innovation and regulatory advancement.
Emerging Healthcare Investment :
Latin America is experiencing increased investment in laboratory quality standards and regulatory compliance, with healthcare systems modernizing their diagnostic capabilities to meet international quality benchmarks and improve patient outcomes.
Regulatory Standardization :
Growing adoption of international quality control standards and ISO certifications across Latin American diagnostic laboratories is driving demand for specialized QC solutions and supporting infrastructure development in the region.
Latin America In Vitro Diagnostics (IVD) Quality Control Market Dynamics
- Brazil's substantial market presence of USD 32.6 million anchors regional expansion, while emerging economies increasingly invest in laboratory infrastructure and quality assurance protocols.
- The 2.6% CAGR reflects a developing market with growing awareness of quality control importance in clinical diagnostics. Key growth drivers include rising healthcare expenditures, expanding laboratory networks, and stricter regulatory requirements for diagnostic accuracy.
- As Latin American countries align with international quality standards and enhance their diagnostic capabilities, demand for IVD quality control solutions will accelerate.
- Market players should focus on cost-effective solutions tailored to regional needs and emerging market dynamics..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Rest Of Middle East & Africa IVD Quality Control Market valued at USD 2.5M in 2025, growing to USD 2.85M by 2030 at 2.6% CAGR
- Rest Of Middle East & Africa market growth is constrained by limited technology access and cost pressures in developing healthcare systems
- Rest Of Middle East & Africa presents emerging opportunities through laboratory modernization and increased regulatory compliance focus
- Rest Of Middle East & Africa growth trajectory is slower than global average, reflecting developing market maturity and infrastructure challenges
In Vitro Diagnostics (IVD) Quality Control Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MOLECULAR DIAGNOSTICS (Technology) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.5% from 2025 to 2030 |
| Largest Segment | QUALITY CONTROL PRODUCTS (Product & Service) |
| Market Size Base Year (Billions) | ~USD 1.65 (2025) |
| Revenue Forecast (Billions) | ~USD 2.15 (2030) |
| Segments Covered | Product & Service, Type, Technology, Manufacturer Type, End User |
Latin America In Vitro Diagnostics (IVD) Quality Control Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Data Management Solutions
- Quality Assurance Services
- Quality Control Products
By Type
- Independent Controls
- Instrument-Specific Controls
- Other Controls
- Serum/Plasma-Based Controls
- Urine-Based Controls
- Whole Blood-Based Controls
By Technology
- Clinical Chemistry
- Coagulation & Hemostasis
- Hematology
- Immunoassays
- Microbiology
- Molecular Diagnostics
- Other Technologies
By Manufacturer Type
- Original Equipment Manufacturer Controls
- Third-Party Controls
By End User
- Academic & Research Institutes
- Clinical Laboratories
- Hospitals
- Other End Users
Target Audience
- Diagnostic Equipment Manufacturers : Manufacturers need Latin America market data to develop region-specific IVD quality control solutions, understand regulatory requirements, and identify growth opportunities in Brazil and emerging markets.
- Laboratory Service Providers : Clinical laboratories and diagnostic centers require insights into quality control standards, compliance requirements, and market trends to enhance their diagnostic capabilities and meet international benchmarks.
- Healthcare System Administrators : Hospital networks and healthcare organizations need market intelligence to allocate budgets for quality control infrastructure, implement standardized protocols, and improve diagnostic accuracy across Latin America.
- Investment and Strategy Consultants : Consultants advising healthcare and diagnostics companies require detailed market analysis to guide investment decisions, identify acquisition targets, and develop market entry strategies in Latin America.
- Regulatory and Compliance Officers : Quality assurance and regulatory professionals need comprehensive market data to understand regional compliance frameworks, benchmark standards, and implement quality control systems aligned with Latin American requirements.
Key Companies in the Latin America In Vitro Diagnostics (IVD) Quality Control Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BIOMERIEUX S.A. | France | Public Company | Clinical microbiology (VITEK, culture media, ID/AST, BACT/ALERT),Syndromic and molecular diagnostics (BIOFIRE, SPOTFIRE, ARGENE, NUCLISENS),Immunoassays and biomarkers (VIDAS, Hybiome CLIA, sepsis markers), |
| CEPHEID INC. | United States | Private Company | GeneXpert instruments and Xpert test cartridges,SmartCycler systems and assays,Collaborative and program-based solutions (e.g., TB, Ebola, USPS BDS), |
| IMMUCOR, INC. | United States | Private Company | Transfusion (serology instruments and reagents),Transplant & Molecular (HLA, HEA/HPA typing, Array Imaging System),Platelet-focused and specialty coagulation products, |
| DIASORIN | Italy | Public Company | Immunodiagnostics – Infectious and Gastrointestinal Diseases,Immunodiagnostics – Endocrinology and Metabolic Disorders,Oncology and Tumor Markers, |
| UNILABS | Switzerland | Private Company | Core laboratory testing,Medical imaging services,Pathology and centres of excellence, |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Clinical Diagnostics,Life Science Research Instruments and Reagents,Other and Services, |
| THERMO FISHER SCIENTIFIC, INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| ABBOTT | United States | Public Company | Diagnostic Products (core lab, rapid, molecular, cardiometabolic, drug testing),Medical Devices (cardiovascular, diabetes care, neuromodulation),Nutritional Products (pediatric, adult, infant formula), |
| LGC LIMITED | South Korea | Public Company | Ethylene-based synthetic resins (EVA, HDPE, LDPE, LLDPE, POE, metallocene PE, UNIQABLE),Styrene-based resins (ABS, ASA, EPS, PS, SAN),Polycarbonate and polypropylene, |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| QUIDELORTHO CORPORATION | United States | Public Company | Labs (clinical chemistry and immunoassay),Transfusion Medicine,Point of Care (professional and OTC), |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicines),Diagnostics (clinical instruments and consumables), |
| SYSMEX CORPORATION | Japan | Public Company | Hematology analyzers and reagents (XN-Series, XN-V, ProCyte Dx),Coagulation systems and reagents,Blood gas, electrolyte, and urinalysis analyzers, |
| BIO-TECHNE CORPORATION | United States | Public Company | Protein Sciences reagents (cytokines, growth factors, antibodies, small molecules, sera, cell selection),Proteomic and protein analysis instruments and immunoassays,Diagnostics products, controls, calibrators, and assays, |
| MICROBIX BIOSYSTEMS INC. | Canada | Public Company | Antigen and test ingredient business,QAPs branded test controls and quality assessment products,DxTM viral transport medium, |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
BIOMERIEUX S.A.
bioMérieux S.A. is a French public company founded in 1963 that employs 14,894 people. The company operates in the diagnostics and life sciences sector.
CEPHEID INC.
Cepheid Inc. is a private company founded in 1996 in the United States with 1,700 employees. The company specializes in molecular diagnostics and infectious disease testing.
IMMUCOR, INC.
Immucor, Inc. is a private company founded in 1982 in the United States with 1,125 employees. The company focuses on blood bank and transfusion diagnostics.
DIASORIN
DiaSorin is an Italian public company founded in 1968 with 3,242 employees. The company operates in the in vitro diagnostics sector.
UNILABS
Unilabs is a private company founded in 1987 in Switzerland with 1,897 employees. The company provides laboratory and diagnostic services.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a public company founded in 1952 in the United States with 7,450 employees. The company develops and manufactures life science research and clinical diagnostics products.
THERMO FISHER SCIENTIFIC, INC.
Thermo Fisher Scientific, Inc. is a public company founded in 1956 in the United States with 125,000 employees. The company is a global leader in serving science with laboratory equipment, reagents, and analytical instruments.
ABBOTT
Abbott is a public company founded in 1888 in the United States with 115,000 employees. The company operates in diagnostics, medical devices, pharmaceuticals, and nutritional products.
LGC LIMITED
LGC Limited is a public company founded in 1947 in South Korea with 14,019 employees. The company provides testing, proficiency testing, and reference materials services.
SIEMENS HEALTHINEERS AG
Siemens Healthineers AG is a public company founded in 1896 in Germany with 72,369 employees. The company provides medical imaging, laboratory diagnostics, and point-of-care testing solutions.
QUIDELORTHO CORPORATION
QuidelOrtho Corporation is a public company founded in 1979 in the United States with 6,500 employees. The company develops and manufactures rapid diagnostic tests and molecular testing solutions.
DANAHER CORPORATION
Danaher Corporation is a public company founded in 1969 in the United States with 59,000 employees. The company operates across diagnostics, life sciences, and environmental and applied solutions segments.
SYSMEX CORPORATION
Sysmex Corporation is a public company founded in 1968 in Japan with 10,861 employees. The company manufactures hematology analyzers and other in vitro diagnostic systems.
BIO-TECHNE CORPORATION
Bio-Techne Corporation is a public company founded in 1976 in the United States with 3,100 employees. The company develops and manufactures life science tools and bioanalytical instruments.
MICROBIX BIOSYSTEMS INC.
Microbix Biosystems Inc. is a public company founded in 1988 in Canada with 100 employees. The company produces quality control materials and reference standards for diagnostics.
GRIFOLS, S.A.
Grifols, S.A. is a public company founded in 1909 in Spain with 25,000 employees. The company specializes in blood plasma derivatives and diagnostic products.
Countries within Latin America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Brazil | USD 32.6 Million |
| Mexico | USD 16.7 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Insights : Gain comprehensive understanding of Latin America's IVD Quality Control Market dynamics, including country-specific opportunities, growth drivers, and competitive landscape tailored to regional healthcare infrastructure.
- Brazil Market Intelligence : Access detailed analysis of Brazil's USD 32.6 million market, the region's largest opportunity, including market segmentation, key players, and strategic expansion opportunities in Latin America's leading diagnostic hub.
- Growth Forecasting : Leverage accurate 5-year projections (2025-2030) with 2.6% CAGR to inform investment decisions, product development strategies, and market entry timelines specific to Latin American healthcare systems.
- Regulatory Compliance Framework : Understand evolving quality control standards and regulatory requirements across Latin American countries, enabling compliant product positioning and market-aligned solution development for diagnostic laboratories.
- Competitive Positioning : Identify market gaps, emerging opportunities, and competitive advantages in Latin America's developing IVD QC segment to optimize market penetration strategies and establish regional partnerships.
Frequently asked questions
What is the market size of IVD Quality Control in Rest Of Middle East & Africa?
Rest Of Middle East & Africa IVD Quality Control Market is estimated at USD 2.5 million in 2025 and is forecast to reach USD 2.85 million by 2030.
What is the CAGR for Rest Of Middle East & Africa IVD Quality Control Market?
Rest Of Middle East & Africa IVD Quality Control Market is expected to grow at a CAGR of 2.6% from 2025 to 2030.
What are the main drivers of growth in Rest Of Middle East & Africa?
Rest Of Middle East & Africa market growth is driven by increasing regulatory compliance requirements, laboratory modernization initiatives, and rising awareness of quality control standards in emerging healthcare systems.
What challenges does Rest Of Middle East & Africa market face?
Rest Of Middle East & Africa faces challenges including limited access to advanced technologies, cost constraints, varying regulatory frameworks, and developing healthcare infrastructure across the region.
How does Rest Of Middle East & Africa compare to the global market?
Rest Of Middle East & Africa grows at 2.6% CAGR, below the global average of 5.5%, reflecting its developing market status and infrastructure maturity relative to established diagnostic regions.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global IVD quality controls market.
Exhaustive secondary research was done to collect information on the IVD quality controls market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the IVD quality controls market.
The four steps involved in estimating the market size are as follows:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. Here’s the breakdown of tiers: Tier 1 = > USD 100 million, tier 2 = USD 10 million to USD 100 million, and tier 3 = < USD 10 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the IVD quality controls market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size included the following:
Data Triangulation
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
IVD quality controls are standardized materials used to monitor, evaluate, and ensure the accuracy, reliability, and precision of diagnostic testing processes in clinical laboratories. These controls are designed to mimic patient samples and are produced from human-derived matrices such as serum, plasma, urine, or whole blood. IVD quality controls provide a benchmark for validating test system performance, detecting errors, and ensuring regulatory compliance across diverse diagnostic platforms.
Stakeholders
- Senior Management
- End Users
- Finance/Procurement Department
- R&D Department
Report Objectives
- To define, describe, segment, and forecast the global IVD quality controls market by product & service, technology, manufacturer type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall IVD quality controls market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the IVD quality controls market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
- To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region
Get the Full In Vitro Diagnostics (IVD) Quality Control Market Report
Full forecast, segment splits, and company analysis for all In Vitro Diagnostics (IVD) Quality Control Market.
- Canada In Vitro Diagnostics (IVD) Quality Control Market
- US In Vitro Diagnostics (IVD) Quality Control Market
- Germany In Vitro Diagnostics (IVD) Quality Control Market
- UK In Vitro Diagnostics (IVD) Quality Control Market
- France In Vitro Diagnostics (IVD) Quality Control Market
- Italy In Vitro Diagnostics (IVD) Quality Control Market
- Spain In Vitro Diagnostics (IVD) Quality Control Market
- Russia In Vitro Diagnostics (IVD) Quality Control Market
- China In Vitro Diagnostics (IVD) Quality Control Market
- Japan In Vitro Diagnostics (IVD) Quality Control Market
- India In Vitro Diagnostics (IVD) Quality Control Market
- Australia In Vitro Diagnostics (IVD) Quality Control Market
- South Korea In Vitro Diagnostics (IVD) Quality Control Market
- Brazil In Vitro Diagnostics (IVD) Quality Control Market
- Mexico In Vitro Diagnostics (IVD) Quality Control Market
- Saudi Arabia In Vitro Diagnostics (IVD) Quality Control Market
- UAE In Vitro Diagnostics (IVD) Quality Control Market
- Rest Of Europe In Vitro Diagnostics (IVD) Quality Control Market
- Rest Of Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report